The Section of Hematology/Oncology at The University of Chicago is one of the largest subspecialty sections in the Department of Medicine. It is comprised of over 40 full faculty members, 22 fellows, and a professional staff of over 180 full- or part-time employees who are devoted to a mission of excellence in research, patient care, and education. The activities of the Hematology/Oncology faculty encompass a broad range of research activities in both basic and clinical domains. The Section is a national leader in research efforts in the development of new insights in the treatment of cancer and blood disorders. The Section has an active and robust research program that is represented by direct faculty award and/or participation (via subcontracts) in over 30 federally funded grants, approximately 35 non-federally funded research projects, and over 380 industry sponsored clinical trials all of which represents nearly $48M in funding.
-
Industry
-
Research Services
-
Company size
-
51-200 employees
-
Headquarters
-
Chicago, Illinois
-
Type
-
Educational
-
Specialties
-
Genitourinary Oncology, Gynecologic Oncology, Breast Oncology, Leukemia, Lymphoma, Melanoma, Mesothelioma, Myeloma, Sarcoma, Thoracic, Cell Therapy, Preventive Oncology, and Gastrointestinal Oncology
